Baclofen® Sintetica Intrathecal is indicated for patients with severe chronic spasticity originating from Multiple Scelerosis, Trauma or other spinal cord disorders unresponsive to other orally administered antispastic agents and/or for patients that experience serious adverse events from orally administered doses.
Baclofen® Sintetica is available in several concentrations in a “ready to refill” presentation. Baclofen is manufactured in Switzerland under very strict quality standards. It is approved by the Swiss and European authorities based on clinical data on both safety and efficacy of Baclofen® Intrathecal.
For full prescribing information and more information about Baclofen®, please visit: http://mri.medagencies.org/download/BE_H_0152_002_FinalSPC_2of3.pdf
For further information related to Baclofen® and its availability in your country of residence, please contact us at: Phone: +971 4 4227010